-
Covishield dose interval under discussion: NTAGI working group chairman Dr N K Arora
The decision to increase the Covishield dose gap lay in the fundamental scientific reason regarding behaviour of adenovector vaccines.
-
Covid-19: India records 70,421 cases; 3,921 deaths
Recoveries outnumbered daily new cases for the 32nd consecutive day in the country.
-
Covid-19: Daily count in India remains below one lakh mark
The active cases further declined to 10,26,159 comprising 3.49% of the total infections.
-
Covid-19: Daily count in India remains below one lakh
The Covid-19 death toll has climbed to 3,63,079 with 3,403 daily deaths.
-
Vaccination: Reins back in its hand, the Centre should ensure delivery
With the reins of the vaccination programme back in its hands, the Centre cannot afford disorder in the procurement and supply of the jabs to the stat
-
Part-vaccinated and part-neglected world is not going to be safe: Jaishankar
Jaishankar arrived in New York on Sunday evening on his first visit to the US after India entered the UN Security Council as a non-permanent member in
-
Covishield stock for 45+ age group left for 12 days: Atishi
On May 25, of the 43,824 doses administered, over 33,000 were given to those getting their first shots and about 10,000 for those receiving their seco
-
Should policyholders get a choice between Covid-19 vaccine and annual health check-up?
While a routine health check-up is a step towards staying fit, by giving an option for reimbursement of Covid vaccination insurance companies may push
-
Q4 earnings, global cues, Covid updates among key factors that may guide market next week
On the coronavirus front, investors would continuously watch out government's course of action along with progress on the vaccination drive.
-
Q4 earnings, Covid update, macroeconomic data to dictate market trends next week
Cipla, Dr Reddy's Laboratories, L&T and Vedanta are scheduled to announce their Q4 results on May 14
